Similar articles

• TRIPS, pharmaceuticals, developing countries, and the Doha "solution".

  Sykes AO. Sykes AO. Chic J Int Law. 2002 Spring;3(1):47-68. Chic J Int Law. 2002. PMID: 15709299 No abstract available.
• Philippines joins other developing countries in limiting prices of drugs.

  Bland B. Bland B. BMJ. 2009 Aug 3;339:b3151. doi: 10.1136/bmj.b3151. BMJ. 2009. PMID: 19651688 No abstract available.
• More drugs, less protection.

  [No authors listed] [No authors listed] Nature. 2002 Sep 19;419(6904):233. doi: 10.1038/419233a. Nature. 2002. PMID: 12239521 No abstract available.
• The concept of essential medicines: lessons for rich countries.

  Hogerzeil HV. Hogerzeil HV. BMJ. 2004 Nov 13;329(7475):1169-72. doi: 10.1136/bmj.329.7475.1169. BMJ. 2004. PMID: 15539676 Free PMC article. Review.
• [Drugs in the European Union: the health-market complex].

  Antoñanzas F, Rodríguez R, Sacristán JA, Illa R. Antoñanzas F, et al. Gac Sanit. 2005 Mar-Apr;19(2):151-67. doi: 10.1157/13074370. Gac Sanit. 2005. PMID: 15860163 Review. Spanish.